Hypoxia, inflammation, and the tumor microenvironment in metastatic disease - Wikidata - awgldk - TriplyDB

Hypoxia, inflammation, and the tumor microenvironment in metastatic disease

Hypoxia, inflammation, and the tumor microenvironment in metastatic disease

http://www.wikidata.org/entity/Q33576030

about

Tumor refractoriness to anti-VEGF therapy Innate immunity and hepatocarcinoma: Can toll-like receptors open the door to oncogenesis?Cell-cell and cell-matrix dynamics in intraperitoneal cancer metastasis Hypoxia regulates global membrane protein endocytosis through caveolin-1 in cancer cells.Relationship between hypoxia and response to antiangiogenic therapy in metastatic colorectal cancer The ever-expanding role of HIF in tumour and stromal biology Q6, a novel hypoxia-targeted drug, regulates hypoxia-inducible factor signaling via an autophagy-dependent mechanism in hepatocellular carcinoma Metastasis suppressor genes at the interface between the environment and tumor cell growth Exosomes reflect the hypoxic status of glioma cells and mediate hypoxia-dependent activation of vascular cells during tumor development A concerted HIF-1α/MT1-MMP signalling axis regulates the expression of the 3BP2 adaptor protein in hypoxic mesenchymal stromal cells High-precision, non-invasive anti-microvascular approach via concurrent ultrasound and laser irradiation.Antiangiogenesis strategies revisited: from starving tumors to alleviating hypoxia.Toward predicting metastatic progression of melanoma based on gene expression data.STAT3 or USF2 contributes to HIF target gene specificity.Phase I study of pazopanib plus TH-302 in advanced solid tumors.HIFs enhance the transcriptional activation and splicing of adrenomedullin.Significance of talin in cancer progression and metastasis.A new method for isolation of interstitial fluid from human solid tumors applied to proteomic analysis of ovarian carcinoma tissue Hypoxia-induced invadopodia formation involves activation of NHE-1 by the p90 ribosomal S6 kinase (p90RSK).Hypoxia regulates alternative splicing of HIF and non-HIF target genes.Differential pattern and prognostic significance of CD4+, FOXP3+ and IL-17+ tumor infiltrating lymphocytes in ductal and lobular breast cancers.Tumor interstitial fluid pressure-a link between tumor hypoxia, microvascular density, and lymph node metastasis Evaluation of characteristics of CD44+CD117+ ovarian cancer stem cells in three dimensional basement membrane extract scaffold versus two dimensional monocultures Glial progenitors as targets for transformation in glioma.Hypoxia and the extracellular matrix: drivers of tumour metastasis Movers and shakers: cell cytoskeleton in cancer metastasis.18F-FAZA PET imaging response tracks the reoxygenation of tumors in mice upon treatment with the mitochondrial complex I inhibitor BAY 87-2243 Molecular and functional imaging of invasion and metastasis: windows into the metastatic cascade.Akt2 regulates all Akt isoforms and promotes resistance to hypoxia through induction of miR-21 upon oxygen deprivation.Intracellular coexpression of CXC- and CC- chemokine receptors and their ligands in human melanoma cell lines and dynamic variations after xenotransplantation.ROS enhances CXCR4-mediated functions through inactivation of PTEN in prostate cancer cells.Metastasis-associated gene, mag-1 improves tumour microenvironmental adaptation and potentiates tumour metastasis.The primary cilium as a biomarker in the hypoxic adaptation of bone marrow-derived mesenchymal stromal cells: a role for the secreted frizzled-related proteins Chronic inflammation and immunologic-based constraints in malignant disease.Bioengineering embryonic stem cell microenvironments for the study of breast cancer Hypoxia induced HMGB1 and mitochondrial DNA interactions mediate tumor growth in hepatocellular carcinoma through Toll-like receptor 9 18F-EF5 PET Is Predictive of Response to Fractionated Radiotherapy in Preclinical Tumor Models Active roles of tumor stroma in breast cancer metastasis The molecular biology of brain metastasis Metabolic abnormalities in pituitary adenoma patients: a novel therapeutic target and prognostic factor

P2860

Q26747678-F3CB139F-B1DA-4E02-9243-1018569BA575 Q26770029-779976DC-83F9-4A81-BB44-380BB22DA3E2 Q26851836-D26D82D0-EB4D-4F04-99FC-DC39F4DE3662 Q27319546-F336E6A3-4469-4ABD-B4EA-EA8E0860554C Q28068654-66866FDD-493C-43E2-8677-3182CFFD013E Q28079015-4E5BCCD5-2668-4988-800A-EFE9FCCCD73E Q28301777-C74EEAB7-4854-4428-84E3-05AE859A3BFB Q28394526-2BC9674E-D673-496E-9380-DA6B3D8432A6 Q28397739-C07456B6-84EE-4563-BD10-1EC6E2E924ED Q30010277-9F398349-94FB-4DF0-BDE9-C3A6B1A81CAC Q30365660-F2C75A80-FD06-4F62-9036-FF95224751EC Q30399006-D769893D-309F-4032-B315-ED833E15D685 Q30924798-4EF783A3-351B-4E48-9D8F-82E894636DFA Q31132835-5905FBC8-D376-4664-BA84-FB1F8FCB9153 Q33439635-C0E358BD-E608-4AAC-8152-37B609FDD62A Q33611004-16977B13-C2D6-4B64-8E39-01A2DAEE2E56 Q33763551-021324AB-7388-47CD-BF06-AF7C71553CE0 Q33889245-EF12C522-DD18-4751-96EE-E91AFD8309C1 Q34117013-0E7327BE-958C-43A2-9A5F-1963361C9786 Q34177914-6F905B7C-4D33-494E-A5D2-71E5FEC576C6 Q34218825-92F2AE31-8D1A-4072-A69C-DD450CDBF878 Q34347257-85E0C9B4-F398-4DAA-B41D-BABA2B9B8F6F Q34569444-5D9E0BE0-5398-41F9-9D16-EAAF42920C82 Q34735661-88EF551A-3815-4B62-9E11-FBFF6C1669FA Q34820282-23A3A9DF-1DF3-4D59-A6B9-F156B7AA889C Q34914057-84E549E4-6EB6-4BFA-AA5F-42B199208B88 Q34979821-1377EC38-C595-45D0-8520-558AF7D443A6 Q35064453-90A679E4-6A66-439F-90D0-06BC427C6CD0 Q35085751-BF314057-1932-423D-B6A5-E1182B040798 Q35100014-B02F0D28-604D-4324-8A9A-1D80DE936B92 Q35185336-F6A44C15-FB26-4484-BF0A-C9A55C0F43A2 Q35370402-B0F4B4E1-AE1F-4F2A-8856-DF94317AFA60 Q35440270-7B24570F-F773-4C3E-AB19-47025BE351F3 Q35575974-B4F73E94-914F-4674-8B4D-58F783999899 Q35600151-7D752BC3-5DDE-4B24-AE90-2770844DC9B6 Q35762937-754C858E-3A41-4B09-9452-114A111EE149 Q35797158-7B132502-6DD1-4507-B676-4CCF47FCCC18 Q35810840-8DF86197-25E2-4ADE-B115-CB8745E98A55 Q35864968-53270FDB-5E41-444C-BC53-1F08D1211D5A Q35935026-8EC09900-8CC4-40B1-9368-837D03CD9AE9

P2860

Hypoxia, inflammation, and the tumor microenvironment in metastatic disease

http://www.wikidata.org/entity/Q33576030

description

2010 nî lūn-bûn

@nan

2010 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Hypoxia, inflammation, and the tumor microenvironment in metastatic disease

@ast

Hypoxia, inflammation, and the tumor microenvironment in metastatic disease

@en

Hypoxia, inflammation, and the tumor microenvironment in metastatic disease.

@nl

type

label

Hypoxia, inflammation, and the tumor microenvironment in metastatic disease

@ast

Hypoxia, inflammation, and the tumor microenvironment in metastatic disease

@en

Hypoxia, inflammation, and the tumor microenvironment in metastatic disease.

@nl

prefLabel

Hypoxia, inflammation, and the tumor microenvironment in metastatic disease

@ast

Hypoxia, inflammation, and the tumor microenvironment in metastatic disease

@en

Hypoxia, inflammation, and the tumor microenvironment in metastatic disease.

@nl

P1433

Q33576030-04DA5132-E105-4DFF-BC23-BBBA1FD7E637

P1476

Q33576030-DC42EABB-4874-444F-8A88-C1997745E029

P2093

Q33576030-31E13E25-EDC9-4702-8FF6-BCF132E060A6

Q33576030-A50573EE-E013-4F15-A175-B4CED373F768

P2860

Q33576030-0B468ED1-3708-46A3-9A1F-B43379740972

Q33576030-0E222BFF-65EB-4E57-8724-1E975A2D8343

Q33576030-10607972-EAA3-45BC-8837-449A80AB2A2F

Q33576030-1597969A-2FB2-4B97-9448-AAC1397F781D

Q33576030-16442769-C405-4DCA-B936-66F7E1EFD203

Q33576030-17A4CBAE-7F30-4CE9-B7F0-7F39129A361F

Q33576030-1946D6D5-8ABA-4032-B581-3BD07935C867

Q33576030-1E186B9B-B7DB-4D0F-A15A-5BD940C86169

Q33576030-1E995AF7-6B30-4FC1-870A-9F39C3B0C68B

Q33576030-21C27EAA-2CBA-4C48-BB66-506E56865F15

P2888

Q33576030-0050FCCD-B058-4603-977F-4224F600B7EE

P304

Q33576030-68D70300-7C06-46E8-9B67-19B312DD80BF

P31

Q33576030-62C12AF2-4888-460A-B7C5-4F387635941E

P356

Q33576030-02807FFA-E22C-4EC6-8950-E23F3A59BD97

P433

Q33576030-84F8FC9E-54F9-4E87-AC2F-01307A92759D

P478

Q33576030-CA2DA1F5-2354-4BB1-831F-69D212DE3BD5

P577

Q33576030-36EC51DD-1812-406B-AFEA-1534C42D38B5

P6179

Q33576030-220006C9-F571-449C-BAA6-0BDB6657D5DF

P698

Q33576030-2A52C73D-CB4A-4A49-A55D-C1F0DC2794A3

P921

Q33576030-036ADB5C-FB62-47F7-B7CB-57F8A5C6B644

P932

Q33576030-2EF29248-D6B6-477B-A7DC-5F4795C45C9D

P356

S10555-010-9224-5

P1433

Cancer and Metastasis Reviews

P1476

Hypoxia, inflammation, and the tumor microenvironment in metastatic disease

@en

P2093

Amato J Giaccia

http://www.w3.org/2001/XMLSchema#string

Elizabeth C Finger

http://www.w3.org/2001/XMLSchema#string

P2860

C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation

Regulation of the polarity protein Par6 by TGFbeta receptors controls epithelial cell plasticity

Loss of type III transforming growth factor beta receptor expression increases motility and invasiveness associated with epithelial to mesenchymal transition during pancreatic cancer progression

A molecular role for lysyl oxidase-like 2 enzyme in snail regulation and tumor progression

Collagenolytic activity in amphibian tissues: a tissue culture assay

Inflammation and cancer

Tumor-selective response to antibody-mediated targeting of alphavbeta3 integrin in ovarian cancer

Tumor-associated macrophages express lymphatic endothelial growth factors and are related to peritumoral lymphangiogenesis

Lysyl oxidase is essential for normal development and function of the respiratory system and for the integrity of elastic and collagen fibers in various tissues

Hypoxia attenuates the expression of E-cadherin via up-regulation of SNAIL in ovarian carcinoma cells

P2888

s10555-010-9224-5

P304

285-293

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S10555-010-9224-5

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

29

http://www.w3.org/2001/XMLSchema#string

P577

2010-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1039149383

http://www.w3.org/2001/XMLSchema#string

P698

20393783

http://www.w3.org/2001/XMLSchema#string

P921

P932

4012531

http://www.w3.org/2001/XMLSchema#string